Hepatitis B virus (HBV) mutations associated with lamivudine resistance in human immunodeficiency virus (HIV)-infected patients.

被引：0
|
作者：
Thibault, V
Benhamou, Y
Seguret, C
Bocher, M
Katlama, C
Bricaire, F
Opolon, P
Poynard, T
Huraux, JM
机构：
[1] Grp Hosp Pitie Salpetriere, Serv Malad Infect, F-75634 Paris, France
[2] Grp Hosp Pitie Salpetriere, Serv Hepatogastroenterol, F-75634 Paris, France
[3] Grp Hosp Pitie Salpetriere, Virol Lab, F-75634 Paris, France
来源：
HEPATOLOGY | 1998年 / 28卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1291
引用
收藏
页码：485A / 485A
页数：1
相关论文
共 50 条
  • [21] SYPHILITIC HEPATITIS IN HUMAN IMMUNODEFICIENCY VIRUS (HIV)-INFECTED PATIENTS
    Rabinowich, L.
    Katchman, E.
    Mlynarsky, L.
    Shibolet, O.
    Turner, D.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S329 - S329
  • [22] Hepatitis B virus genetic multiplicity and the associated HBV lamivudine resistance mutations in HBV/HIV co-infection in Western Kenya: A review article
    Wandera, Bernard Onyango
    Onyango, David Miruka
    Musyoki, Stanslaus Kiilu
    INFECTION GENETICS AND EVOLUTION, 2022, 98
  • [23] Hepatitis B virus mutations associated with lamivudine therapy in patients with chronic hepatitis B
    Asahina, Y
    Enomoto, N
    Nagayama, K
    Kurosaki, M
    Ogura, Y
    Izumi, N
    Marumo, F
    Sato, C
    HEPATOLOGY RESEARCH, 1999, 15 (02) : 145 - 156
  • [24] Mutations associated with lamivudine-resistance in therapy-naive hepatitis B virus (HBV) infected patients with and without HIV co-infection: Implications for antiretroviral therapy in HBV and HIV co-infected south African patients
    Selabe, S. Gloria
    Lukhwareni, Azwidowi
    Song, Ernest
    Leeuw, Yeegan G. M.
    Burnett, Rosemary J.
    Mphahlele, M. Jeffrey
    JOURNAL OF MEDICAL VIROLOGY, 2007, 79 (11) : 1650 - 1654
  • [25] Hepatitis B Virus Genotypes and Antiviral Resistance Mutations in Romanian HIV-HBV Co-Infected Patients
    Sultana, Camelia
    Casian, Mihnea
    Oprea, Cristiana
    Ianache, Irina
    Grancea, Camelia
    Chiriac, Daniela
    Ruta, Simona
    MEDICINA-LITHUANIA, 2022, 58 (04):
  • [26] Genotypic succession of mutations of the hepatitis B virus polymerase associated with lamivudine resistance
    Gutfreund, KS
    Williams, M
    George, R
    Bain, VG
    Ma, MM
    Yoshida, EM
    Villeneuve, JP
    Fischer, KP
    Tyrrell, DLJ
    JOURNAL OF HEPATOLOGY, 2000, 33 (03) : 469 - 475
  • [27] Antisense phosphorothioates as antivirals against human immunodeficiency virus (HIV) and hepatitis B virus (HBV)
    Matsukura, M
    Koike, K
    Zon, G
    TOXICOLOGY LETTERS, 1995, 82-3 : 435 - 438
  • [28] HUMAN IMMUNODEFICIENCY VIRUS (HIV) AND HEPATITIS-B VIRUS (HBV) INFECTIONS IN AN ALCOHOLIC POPULATION
    JACOBSON, JM
    WORNER, TM
    SACKS, H
    LIEBER, CS
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1988, 12 (01) : 192 - 192
  • [29] Chronic active hepatitis B exacerbations in human immunodeficiency virus-infected patients following development of resistance to or withdrawal of lamivudine
    Bessesen, M
    Ives, D
    Condreay, L
    Lawrence, S
    Sherman, KE
    CLINICAL INFECTIOUS DISEASES, 1999, 28 (05) : 1032 - 1035
  • [30] Physicians' assessments of the utility of health states associated with Human Immunodeficiency Virus (HIV) and Hepatitis B Virus (HBV) Infection
    D. K. Owens
    A. B. Cardinalli
    R. F. Nease
    Quality of Life Research, 1997, 6 (1) : 77 - 86
12345